Naveen Karkada

Efficacy, safety, and immunogenicity of the human papillomavirus 16/18 AS04-adjuvanted vaccine in women older than 25 years: 7-year follow-up of the phase 3, double-blind, randomised controlled VIVIANE study

Cosette M. Wheeler, S. Rachel Skinner, Maria Rowena Del Rosario‐Raymundo et al. · The Lancet Infectious Diseases · 2016 · 192 citations

Veterinary Medicine, Geriatric Medicine, Immunology +15

Evaluation of Type Replacement Following HPV16/18 Vaccination: Pooled Analysis of Two Randomized Trials

Joseph E. Tota, Frank Struyf, Marko Merikukka et al. · JNCI Journal of the National Cancer Institute · 2016 · 66 citations · Full text

Veterinary Medicine, Infectious Diseases, Preventive Medicine +17

Association of serum anti-rotavirus immunoglobulin A antibody seropositivity and protection against severe rotavirus gastroenteritis

Brigitte Cheuvart, Kathleen M. Neuzil, A. Duncan Steele et al. · Human Vaccines & Immunotherapeutics · 2013 · 60 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

A ten-year study of immunogenicity and safety of the AS04-HPV-16/18 vaccine in adolescent girls aged 10-14 years

Tino F. Schwarz, Li‐Min Huang, Alejandra Valencia et al. · Human Vaccines & Immunotherapeutics · 2019 · 57 citations · Full text

Veterinary Medicine, Immunology, Pediatrics +17

Efficacy, immunogenicity and safety of the AS04‐HPV‐16/18 vaccine in Chinese women aged 18‐25 years: End‐of‐study results from a phase II/III, randomised, controlled trial

Fengcai Zhu, Shangying Hu, Ying Hong et al. · Cancer Medicine · 2019 · 57 citations · Full text

Veterinary Medicine, Immunology, Oncology +16